Literature DB >> 15126514

The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.

Boryana Todorova1, Agata Kubaszek, Jussi Pihlajamäki, Jaana Lindström, Johan Eriksson, Timo T Valle, Helena Hämäläinen, Pirjo Ilanne-Parikka, Sirkka Keinänen-Kiukaanniemi, Jaakko Tuomilehto, Matti Uusitupa, Markku Laakso.   

Abstract

In population-based studies, dyslipidemia related to insulin resistance (high triglyceride level and low high-density lipoprotein cholesterol level) is a risk factor for type 2 diabetes. Therefore, variants in genes regulating lipid and lipoprotein metabolism are potential candidate genes for diabetes. We investigated whether the G-250A polymorphism of the hepatic lipase gene (LIPC) predicts the conversion from impaired glucose tolerance (IGT) to type 2 diabetes in the Finnish Diabetes Prevention Study. This study randomized subjects to either the intervention group (lifestyle modification aimed at weight loss, such as changes in diet and increased physical exercise) or the control group. Genotyping at position -250 of the LIPC gene was performed with PCR amplification, DraI enzyme digestion, and gel electrophoresis in 490 subjects with IGT whose DNA was available. In the entire study population, the conversion rate to type 2 diabetes was 17.8% among subjects with the G-250G genotype and 10.7% among subjects with the -250A allele (P = 0.032). In univariate analysis, the odds ratio for the G-250G genotype to predict the conversion from IGT to type 2 diabetes was 1.80 (95% confidence interval, 1.05-3.10; P = 0.034). In multivariate logistic regression analysis, the G-250G genotype predicted the conversion to diabetes independently of the study group (control or intervention), gender, weight, waist circumference at baseline, and change in weight and waist circumference. In the intervention group, 13.0% of subjects with the G-250G genotype and 1.0% of the subjects with the -250A allele converted to diabetes (P = 0.001). We conclude that the G-250G genotype of the LIPC gene is a risk factor for type 2 diabetes. Therefore, genes regulating lipid and lipoprotein metabolism may be potential candidate genes for type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126514     DOI: 10.1210/jc.2003-031325

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes.

Authors:  Peter Weyrich; Norbert Stefan; Hans-Ulrich Häring; Markku Laakso; Andreas Fritsche
Journal:  J Mol Med (Berl)       Date:  2006-12-13       Impact factor: 4.599

Review 2.  Dietary fat, genes and insulin sensitivity.

Authors:  José López-Miranda; Pablo Pérez-Martínez; Carmen Marin; Francisco Fuentes; Javier Delgado; Francisco Pérez-Jiménez
Journal:  J Mol Med (Berl)       Date:  2006-12-15       Impact factor: 4.599

3.  Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions.

Authors:  Konstantinos Kantartzis; Andreas Fritsche; Fausto Machicao; Michael Stumvoll; Jürgen Machann; Fritz Schick; Hans-Ulrich Häring; Norbert Stefan
Journal:  J Mol Med (Berl)       Date:  2006-09-26       Impact factor: 4.599

4.  Dietary Fat Intake Modifies the Effect of a Common Variant in the LIPC Gene on Changes in Serum Lipid Concentrations during a Long-Term Weight-Loss Intervention Trial.

Authors:  Min Xu; San San Ng; George A Bray; Donna H Ryan; Frank M Sacks; Guang Ning; Lu Qi
Journal:  J Nutr       Date:  2015-04-29       Impact factor: 4.798

5.  The rs2070895 (-250G/A) Single Nucleotide Polymorphism in Hepatic Lipase (HL) Gene and the Risk of Coronary Artery Disease in North Indian Population: A Case-Control Study.

Authors:  Pratima Verma; Dileep Kumar Verma; Rishi Sethi; Shraddha Singh; Akhilesh Krishna
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 6.  Complexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?

Authors:  Jim Kaput; Kevin Dawson
Journal:  Mutat Res       Date:  2007-05-05       Impact factor: 2.433

7.  Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.

Authors:  N Siitonen; J Lindström; J Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; J Tuomilehto; M Laakso; M Uusitupa
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

8.  Interaction between cholesteryl ester transfer protein and hepatic lipase encoding genes and the risk of type 2 diabetes: results from the Telde study.

Authors:  Laura López-Ríos; Francisco J Nóvoa; Ricardo Chirino; Francisco Varillas; Mauro Boronat-Cortés; Ana M Wägner
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

9.  No interactions between previously associated 2-hour glucose gene variants and physical activity or BMI on 2-hour glucose levels.

Authors:  Robert A Scott; Audrey Y Chu; Niels Grarup; Alisa K Manning; Marie-France Hivert; Dmitry Shungin; Anke Tönjes; Ajay Yesupriya; Daniel Barnes; Nabila Bouatia-Naji; Nicole L Glazer; Anne U Jackson; Zoltán Kutalik; Vasiliki Lagou; Diana Marek; Laura J Rasmussen-Torvik; Heather M Stringham; Toshiko Tanaka; Mette Aadahl; Dan E Arking; Sven Bergmann; Eric Boerwinkle; Lori L Bonnycastle; Stefan R Bornstein; Eric Brunner; Suzannah J Bumpstead; Soren Brage; Olga D Carlson; Han Chen; Yii-Der Ida Chen; Peter S Chines; Francis S Collins; David J Couper; Elaine M Dennison; Nicole F Dowling; Josephine S Egan; Ulf Ekelund; Michael R Erdos; Nita G Forouhi; Caroline S Fox; Mark O Goodarzi; Jürgen Grässler; Stefan Gustafsson; Göran Hallmans; Torben Hansen; Aroon Hingorani; John W Holloway; Frank B Hu; Bo Isomaa; Karen A Jameson; Ingegerd Johansson; Anna Jonsson; Torben Jørgensen; Mika Kivimaki; Peter Kovacs; Meena Kumari; Johanna Kuusisto; Markku Laakso; Cécile Lecoeur; Claire Lévy-Marchal; Guo Li; Ruth J F Loos; Valeri Lyssenko; Michael Marmot; Pedro Marques-Vidal; Mario A Morken; Gabriele Müller; Kari E North; James S Pankow; Felicity Payne; Inga Prokopenko; Bruce M Psaty; Frida Renström; Ken Rice; Jerome I Rotter; Denis Rybin; Camilla H Sandholt; Avan A Sayer; Peter Shrader; Peter E H Schwarz; David S Siscovick; Alena Stancáková; Michael Stumvoll; Tanya M Teslovich; Gérard Waeber; Gordon H Williams; Daniel R Witte; Andrew R Wood; Weijia Xie; Michael Boehnke; Cyrus Cooper; Luigi Ferrucci; Philippe Froguel; Leif Groop; W H Linda Kao; Peter Vollenweider; Mark Walker; Richard M Watanabe; Oluf Pedersen; James B Meigs; Erik Ingelsson; Inês Barroso; Jose C Florez; Paul W Franks; Josée Dupuis; Nicholas J Wareham; Claudia Langenberg
Journal:  Diabetes       Date:  2012-03-13       Impact factor: 9.461

10.  Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.

Authors:  Toni I Pollin; Tamara Isakova; Kathleen A Jablonski; Paul I W de Bakker; Andrew Taylor; Jarred McAteer; Qing Pan; Edward S Horton; Linda M Delahanty; David Altshuler; Alan R Shuldiner; Ronald B Goldberg; Jose C Florez; Paul W Franks
Journal:  PLoS Genet       Date:  2012-08-30       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.